Five‐year long‐term clinical follow‐up of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with <i>de novo</i> coronary artery lesions: The SPIRIT FIRST trial

201075 citationsJournal Article

Authors

The favorable 5-year long term clinical outcome of the EES is consistent with the results from other studies of the EES with shorter follow-up.

Good health and well-being

Published in: Catheterization and Cardiovascular Interventions

Volume 75, Issue 7, pp. 997-1003

Field-Weighted Citation Impact: 13.04